Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.

Todorova VK, Makhoul I, Siegel ER, Wei J, Stone A, Carter W, Beggs ML, Owen A, Klimberg VS

Open source

DOI
10.1371/journal.pone.0160224
Published
2016
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0160224,
  title = {Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.},
  author = {Todorova VK and Makhoul I and Siegel ER and Wei J and Stone A and Carter W and Beggs ML and Owen A and Klimberg VS},
  year = {2016},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0160224},
  url = {https://doi.org/10.1371/journal.pone.0160224}
}

RIS

TY  - JOUR
TI  - Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
AU  - Todorova VK
AU  - Makhoul I
AU  - Siegel ER
AU  - Wei J
AU  - Stone A
AU  - Carter W
AU  - Beggs ML
AU  - Owen A
AU  - Klimberg VS
PY  - 2016
JO  - PloS one
DO  - 10.1371/journal.pone.0160224
UR  - https://doi.org/10.1371/journal.pone.0160224
ER  - 

APA

VK, T., I, M., ER, S., J, W., A, S., W, C., ML, B., A, O., & VS, K. (2016). Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.. PloS one. https://doi.org/10.1371/journal.pone.0160224

Source records